These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 11281956)

  • 21. No association between lithium full responders and the DRD1, DRD2, DRD3, DAT1, 5-HTTLPR and HTR2A genes in a Sardinian sample.
    Manchia M; Congiu D; Squassina A; Lampus S; Ardau R; Chillotti C; Severino G; Del Zompo M
    Psychiatry Res; 2009 Sep; 169(2):164-6. PubMed ID: 19647327
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The association study of three FYN polymorphisms with prophylactic lithium response in bipolar patients.
    Szczepankiewicz A; Skibinska M; Suwalska A; Hauser J; Rybakowski JK
    Hum Psychopharmacol; 2009 Jun; 24(4):287-91. PubMed ID: 19330793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. No association between D3 dopamine receptor (DRD3) alleles and cocaine dependence.
    Freimer M; Kranzler H; Satel S; Lacobelle J; Skipsey K; Charney D; Gelernter J
    Addict Biol; 1996; 1(3):281-7. PubMed ID: 12893467
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lithium therapy for unipolar and bipolar depression among the middle-aged and older adult patient subpopulation.
    Lepkifker E; Iancu I; Horesh N; Strous RD; Kotler M
    Depress Anxiety; 2007; 24(8):571-6. PubMed ID: 17133442
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopamine D2 receptor gene not associated with symptomatology of mood disorders.
    Serretti A; Smeraldi E
    Am J Med Genet; 1999 Aug; 88(4):294-7. PubMed ID: 10402492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dopamine receptor D4 gene is not associated with major psychoses.
    Serretti A; Lilli R; Di Bella D; Bertelli S; Nobile M; Novelli E; Catalano M; Smeraldi E
    Am J Med Genet; 1999 Oct; 88(5):486-91. PubMed ID: 10490704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rationale for using lithium in combination with other mood stabilizers in the management of bipolar disorder.
    Goodwin FK
    J Clin Psychiatry; 2003; 64 Suppl 5():18-24. PubMed ID: 12720480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rational polypharmacy in the bipolar affective disorders.
    Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
    Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predicting response to lithium in mood disorders: role of genetic polymorphisms.
    Serretti A; Artioli P
    Am J Pharmacogenomics; 2003; 3(1):17-30. PubMed ID: 12562213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of the D3 dopamine receptor in nicotine sensitization.
    Smith LN; Bachus SE; McDonald CG; Smith RF
    Behav Brain Res; 2015 Aug; 289():92-104. PubMed ID: 25907750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Venlafaxine versus lithium monotherapy of rapid and non-rapid cycling patients with bipolar II major depressive episode: a randomized, parallel group, open-label trial.
    Amsterdam JD; Wang CH; Shwarz M; Shults J
    J Affect Disord; 2009 Jan; 112(1-3):219-30. PubMed ID: 18486235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tyrosine hydroxylase gene associated with depressive symptomatology in mood disorder.
    Serretti A; Macciardi F; Verga M; Cusin C; Pedrini S; Smeraldi E
    Am J Med Genet; 1998 Mar; 81(2):127-30. PubMed ID: 9613850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of association between dopamine D3 receptor Ser9Gly polymorphism and schizophrenia in Han Chinese population.
    Chang HA; Lu RB; Lin WW; Chang CC; Chen CL; Shy MJ; Huang SY
    Acta Neuropsychiatr; 2007 Dec; 19(6):344-50. PubMed ID: 26952999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prophylactic treatment of mood disorders: cost effectiveness analysis comparing lithium and carbamazepine].
    Dardennes R; Lafuma A; Watkins S
    Encephale; 1999; 25(5):391-400. PubMed ID: 10598301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The COMT and DRD3 genes interacted in bipolar I but not bipolar II disorder.
    Lee SY; Chen SL; Chen SH; Huang SY; Tzeng NS; Chang YH; Wang CL; Lee IH; Yeh TL; Yang YK; Lu RB
    World J Biol Psychiatry; 2011 Aug; 12(5):385-91. PubMed ID: 20698735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Calcium antagonists and lithium in preventive treatment of manic-depressive disorder].
    Sarfati Y; Spadone C; Vanelle JM; Lôo H
    Encephale; 1996; 22(2):149-53. PubMed ID: 8706625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between prophylactic effect of lithium therapy and family history of affective disorders.
    Engström C; Aström M; Nordqvist-Karlsson B; Adolfsson R; Nylander PO
    Biol Psychiatry; 1997 Sep; 42(6):425-33. PubMed ID: 9285078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ser9Gly polymorphism in the dopamine D3 receptor gene is not associated with essential hypertension in the Japanese.
    Soma M; Nakayama K; Rahmutula D; Uwabo J; Sato M; Kunimoto M; Aoi N; Kosuge K; Kanmatsuse K
    Med Sci Monit; 2002 Jan; 8(1):CR1-4. PubMed ID: 11796958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of lithium response in affective disorders.
    Ananth J; Pecknold JC
    J Clin Psychiatry; 1978 Feb; 39(2):95-100. PubMed ID: 344305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MMPI as a measure of subthreshold and residual psychopathology among the offspring of lithium responsive and non-responsive bipolar parents.
    Demidenko N; Grof P; Alda M; Deshauer D; Duffy A
    Bipolar Disord; 2004 Aug; 6(4):323-8. PubMed ID: 15225151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.